Terms: = Germ cell tumor AND AFP, AFPD, FETA, HPAFP AND Clinical Outcome
7 results:
1. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular germ cell Cancers Before, During and After Chemotherapy.
Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
[TBL] [Abstract] [Full Text] [Related]
2. Management of mature pineal region teratomas in pediatric age group.
Tanrıkulu B; Özek MM
Childs Nerv Syst; 2020 Jan; 36(1):153-163. PubMed ID: 31144023
[TBL] [Abstract] [Full Text] [Related]
3. Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
Urol Clin North Am; 2007 May; 34(2):219-25; abstract ix-x. PubMed ID: 17484926
[TBL] [Abstract] [Full Text] [Related]
4. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.
Heerema-McKenney A; Harrison MR; Bratton B; Farrell J; Zaloudek C
Am J Surg Pathol; 2005 Jan; 29(1):29-38. PubMed ID: 15613854
[TBL] [Abstract] [Full Text] [Related]
5. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract] [Full Text] [Related]
7. Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma".
Norgaard-Pedersen B; Albrechtsen R; Teilum G
Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):573-89. PubMed ID: 52995
[TBL] [Abstract] [Full Text] [Related]
